Skip to content
OpenCapital
Get started

Labcorp Holdings LH Diagnostics — Revenue

Other segment segments

Biopharma Laboratory Services
$780.6M+8.2%

Similar metrics at other companies

Revvity logo
RVTYDiagnostics — Segment revenue
$349.27M+7.7%
Danaher logo
DHRDiagnostics — Sales
$2.42B-1.3%
GeneDx Holdings logo
WGSDiagnostic Test — Total Revenue
$101.3M+18.1%
Biodesix, Inc. logo
BDSXDiagnostic Tests — Revenue
$22.29M+36.6%
Tempus AI, Inc. logo
TEMDiagnostics — Revenue
$261.1M+34.7%
Medline, Inc. logo
MDLNLaboratory and Diagnostics — Net Sales
$293M+0.7%

Other financials

Income statement

See full
Revenue$3.5B+5.8%
Gross profit$1.0B+6.9%
Operating income$380.8M+16.8%
Net income$277.8M+30.5%
EPS (diluted)$3.35+32.9%

Balance sheet

See full
Cash & equivalents$981.1M+166%
Total debt$7.2B+11.1%
Total equity$8.7B+5.1%
Total assets$19.1B+8.4%

Cash flow

See full
Operating cash flow$191.5M+935%
CapEx$121.0M-4.0%
Free cash flow$70.5M+166%

Valuation

See full
Market cap$22.96B+9.4%
Enterprise value$29.22B+10.7%
P/E24.4×-3.1×
P/S1.6×+0.1×

Profitability

See full
Gross margin28.8%+0.9pp
Operating margin10.2%+1.9pp
Net margin6.7%+1.1pp
FCF margin9.8%+1.0pp

Returns & leverage

See full
Return on equity11.1%+2.1pp
Debt / equity0.8×0.0×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's diagnostics — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's diagnostics — revenue?
Labcorp Holdings (LH) reported diagnostics — revenue of $2.76B in Q1 2026.
How has Labcorp Holdings's diagnostics — revenue changed year-over-year?
Labcorp Holdings's diagnostics — revenue increased by 5.0% year-over-year, from $2.63B to $2.76B.
What is the long-term trend for Labcorp Holdings's diagnostics — revenue?
Over 4 years (2021 to 2025), Labcorp Holdings's diagnostics — revenue has grown at a 1.2% compound annual growth rate (CAGR), from $10.36B to $10.88B.
What does diagnostics — revenue mean?
This represents the total gross income generated by the diagnostics segment from providing laboratory testing and related services. It is the primary top-line metric for evaluating the segment's market demand and pricing power.